Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J0JY
|
|||
| Former ID |
DNC003077
|
|||
| Drug Name |
Tetradecane
|
|||
| Synonyms |
629-59-4; N-TETRADECANE; Alkanes, C14-16; Tridecane, methyl-; CCRIS 715; Tetradecane, 99%; UNII-03LY784Y58; HSDB 5728; EINECS 211-096-0; NSC 72440; C14H30; BRN 1733859; AI3-04240; CHEBI:41253; BGHCVCJVXZWKCC-UHFFFAOYSA-N; MFCD00008986; 03LY784Y58; 90622-46-1; Tetradecane, analytical standard; Alkanes, C14-30; Tetradekan; n-Teradecane; Tetradecane olefine; EINECS 292-448-0; Paraffinic hydrocarbons (C14-C30); Tetradecane, > AC1L1ZHO; DSSTox_CID_7267; EC 211-096-0; DSSTox_RID_78378; ACMC-1B07Q; DSSTox_GSID_27267
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H30
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCC
|
|||
| InChI |
1S/C14H30/c1-3-5-7-9-11-13-14-12-10-8-6-4-2/h3-14H2,1-2H3
|
|||
| InChIKey |
BGHCVCJVXZWKCC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 629-59-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
115153, 584648, 855216, 3137176, 4863823, 7886420, 8159259, 10530996, 14797461, 24850401, 24867973, 24888861, 24888862, 26697301, 26750592, 29280622, 33045964, 33610554, 37355822, 37370359, 37380382, 39716596, 40006027, 41134470, 46507858, 48417664, 48419463, 49834193, 50049818, 50992868, 56371315, 56436308, 57327577, 57653230, 81061675, 83550646, 85089762, 87575810, 87576095, 91010183, 92297579, 103370922, 104179364, 104328857, 109457213, 119526689, 124756341, 124767551, 124767644, 125264389
|
|||
| ChEBI ID |
CHEBI:41253
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lanosterol synthase (LSS) | Target Info | Inhibitor | [1] |
| BioCyc | Cholesterol biosynthesis II (via 24,25-dihydrolanosterol) | |||
| Cholesterol biosynthesis III (via desmosterol) | ||||
| Cholesterol biosynthesis I | ||||
| Superpathway of cholesterol biosynthesis | ||||
| Lanosterol biosynthesis | ||||
| KEGG Pathway | Steroid biosynthesis | |||
| Metabolic pathways | ||||
| Biosynthesis of antibiotics | ||||
| Panther Pathway | Cholesterol biosynthesis | |||
| Pathwhiz Pathway | Steroid Biosynthesis | |||
| Reactome | Cholesterol biosynthesis | |||
| Activation of gene expression by SREBF (SREBP) | ||||
| WikiPathways | Activation of Gene Expression by SREBP (SREBF) | |||
| SREBP signalling | ||||
| Cholesterol Biosynthesis | ||||
| Cholesterol biosynthesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.